医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Promega PowerPlex® Fusion 6C System Improves Mixture Interpretation with Difficult Forensic Casework Samples

2015年01月29日 PM11:00
このエントリーをはてなブックマークに追加


 

MADISON, Wis.

Promega Corporation announces the release of the PowerPlex® Fusion 6C System, a 6-color, 27-locus multiplex. The system combines common and informative loci to overcome typical challenges faced by laboratories, including sample inhibitors, low levels of input DNA, degradation, and mixtures.

The Promega PowerPlex(R) Fusion 6C System enables greater discriminatory power and improved mixture  ...

The Promega PowerPlex(R) Fusion 6C System enables greater discriminatory power and improved mixture interpretation for challenging forensic casework samples. (Photo: Business Wire)

PowerPlex Fusion 6C includes the 23 loci in the expanded CODIS core loci panel (including SE33), as well as Penta D and Penta E for greater discriminatory power than seen in other available STR systems. Two rapidly-mutating Y-STR loci, DYS570 and DYS576, are included in the multiplex for improved mixture interpretation. Rapid-cycling protocols of approximately one hour allow laboratories to focus on more value-added activities.

Users can consistently generate complete DNA profiles from as little as 200pg of input DNA and usable, partial profiles from input amounts as low as 50pg. PowerPlex Fusion 6C works with difficult casework samples, including inhibitor-laden samples, degraded DNA and mixtures. Optimized protocols are provided for reference, database and paternity testing for a variety of sample types, including FTA® card punches, non-FTA punches and swabs.

The system is designed and QC-tested to allow direct amplification at full- or half-volume (12.5µl) reactions with various recommended protocol modifications, depending on sample type. This provides significant cost savings per reaction.

The PowerPlex Fusion 6C System is configured so that both casework and databasing sections of a laboratory purchase the same kit, simplifying validation and QC efforts.

A poster detailing results from in-house studies on sensitivity, inhibitor tolerance and mixtures will be presented at the 67th Annual American Academy of Forensic Sciences meeting in Orlando, Florida, in February (aafs.org).

Developmental validation efforts are already under way. Promega is seeking United States NDIS approval for the PowerPlex Fusion 6C System.

To learn more, please visit: www.promega.com/fusion6C

Promega Corporation has provided products for DNA-based human identification for over 20 years. Promega is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 3,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, drug discovery and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150129005046/en/

CONTACT

Promega Corporation
Penny Patterson, 608-274-4330
Sr.
Director, Communications
penny.patterson@promega.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Brightree发布面向居家医疗器械的首个患者App
  • Brightreeが初のHME向け患者アプリを発表
  • Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
  • ポットネットワーク・ホールディングスがSEC報告会社登録に基づきPCAOB監査人による完全な監査・レビュー済みの財務報告書を公表
  • Takeda Receives Clearance from the Japan Fair Trade Commission for the Proposed Acquisition of Shire plc